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ciated with tylosis. The only reported association of clino-
dactyly is that with webbing of the toes.s In the family
we studied there were 10 members with clinodactyly-
6 female and 4 male. In 8 cases the curving of the little
finger was bilateral but in 2 this curving was only present
in the left hand. Of those with clinodactyly, 6 were
affected with tylosis as well. Clinodactyly is transmitted
as an autosomal dominant. Lack of complete penetrance.
was shown by the fact that in 6 cases the parents did not
have the condition. In 1 case (N24) neither the parents
nor the grandparents had clinodactyly. These features of
dominant transmission with incomplete penetrance have
been reported by others.s
Is there a genetic linkage between clinodactyly and
tylosis, or is the association purely one of chance? We
were unable to obtain statistically significant results in
favour of genetic linkage, using the sibling pair method
of PenroseY·lS However, assuming that the incidence of
tylosis and clinodactyly in South Africa is 1 in 40,()()()24
and 1 in I,OOOS respectively, the probability of these 2
co~Oitions occurring together is in the region of 1 in 40
miJ1fon.
SUMMARY
In a family affected with tylosis palmaris et plantaris 59
members were studied. The family tree and the mode' of
genetic transmission are outlined. The incidence, histo-
pathology, clinical features, differential diagnosis and treat-
ment of tylosis are discussed. The association of tylosis
and clinodactyly is noted. In addition some of the reported
abnormalities occurring with tylosis are revi"ewed.
We wish to thank Profs. G. A. Elliott, B. J. P. Becker, and
P. V. Tobias for encouragement and a i lance in the pre-
paration of this article; the Photographic Unit of the Depart-
ment of Medicine and Mr. S. Dry of the Anatomy Depart-
ment, Univer ity of the Witwater rand, for reproduction of
the figures; and Dr. K. F. Mills, Superintendent, Johanne-
burg General Hospital, for perrni sion to publish.
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the weight of each subject. During the next 7 days,
trichlormethiazide was given in doses of 4 mg. b.d. Three
grams of potassium chloride were administered in divided
doses daily during the last 3 days of this period. Measure-
ments of weight, urine volume, and electrolyte content




vol. ml. Na K Cl
1,345 164 85 187
2,800 338 986 380
1,810 236 131·9 240
1,770 159 126·6 206
800 65·4 75'5 88'5
940 71'5 110'1 83
1,670 210 266 266
1,960 160 115 225
* Effect of 4 mg. of trichlormethiazide twice daily on urinary
volume, sodium, potassium and chloride excretion in 3 healthy
subjects after a control period of 4 days. Three g. of potassium
chloride were given daily for the last 3 days.








The introduction of the benzothiadiazine djuretics has had
a marked influence on the treatment of patients with
oedema. Modifications of the original molecule have
resulted in preparations which, in the main, vary quantita-
tively in potency but not qualitatively. This paper presents
the effects observed of a recently developed derivative,
trichlormethiazide (3-dichloro-methy1-6-chloro-7-sulfamyl-
3, 4-dihydro-l, 2, 4-benzothiadiazine-I, I-dioxide) (Fig. 1),
on urinary electrolyte excretion in normal subjects and on
patients with fluid retention.
Normal Subjects
Three healthy male medical students were studied. They
were phiced on a standard hQspital diet for 11 days.
During the first 4 days (control period) the 24-hour
excretion of water, sodium, potassium, chloride, bicar-
bonate, and the pH of the urine was measured as well as
'~TricblOI'Illethiazide ('fluitran') was made available for
study Ihrough Dr. M. Tonkin, Medical Director, Scherag
(Pty.) Ltd.
~"~ Final year medical students.






















Fig. 2. The effect of 4 mg. of trichlormethiazide twice
daily on body weight, bicarbonate excretion, and urinary
volume is shown.
In 2 other 'healthy subjects the time of onset and
duration of action of trichlormethiazide were studied.
Urine was collected as above in periods from 8 a.m. - 2
p.m., 2 p.m. - 8 p.m. and 8 p.m. - 8 a.m. over 3 days while
on a standard hospital diet. Trichlormethiazide (8 mg.)
was then given and the effect on urine volume and electro-
lyte excretion observed for a further 60 hours. The results
are shown in Figs. 3 and 4.
11 DAYS
o ~-_--",,-_--..-~__......_,..+__,...,
were continued throughout the study, the urine being
collected and preserved with toluene and thymol. The
results are shown in Tables I and 11 and Fig. 2.
ChlorothiazideHydroClumethiazide




vol. ml. a K Cl
1 - 4 comrol J,51O J50 82 176
5 1,700 J85 136 178
6 1,650 152 118 20
7 2,220 J82 134 229
1,830 209 75 21 J
9 1,680 147 88·5 188
JO 1,140 1 t I 83 J63




Navol. ml. K Cl
J - 4 omrol J,251 180 76 236
5 J,530 345·1 8J·5 306
6 1,000 J38·6 80·6 J86
7 J,770 7J ·3 112·7 204
8 J,050 106·3 109·2 131
9 1,050 43'5 61 64·2
10 730 93'5 74·5 93·5
Jl 900 J33 65 151
TABLE D. EFFECT OF TREATMENT I HEALTHY SUBJEcrs--(CONTD.)*
a: K Na: Cl
SubjeCTs Subjects
J 2 3 J 2 3
1·92 1·83 2·36 ·88 ·88 ·76
3·43 J'36 4·24 ·89 ·671·16
J'79 1·30 J·71 ·99 ·74 ·73
1 ·26 1. 36 ·64 ·78·80·35
·86 2·79 ·98 ·74 1·00 ·81
·66 1·66 ·72 ·87 ·78 ·68
·791·33 ]·26 ·79 ·681·00
]']5 ],55 2·04 ·75 ·73 ·88
* la: K and a :CI urinary excretion ralios before and
during the administration of 4 mg. of trichlormethiazide twice
dailY to 3 healthy subjects.
R?O*....... HF-~ V I ~:
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Trichlormethiazide 1A Flumethiazide 18
Fig. J. The chemical formulae of some of the benzo-
tbiadiazine diuretics are shown. These are all substitutes






Patients with Fluid Retention
17 patients with fluid retention (9 with cardiac failure.
1 with the nephrotic syndrome, and 1 with steroid-induced
oedema) were treated with 4 mg. of trichlormethiazide
twice daily. Two patients had gross oedema, 9 mild oedema,
and 6 had left ventricular failure without manifest
oedema. Potassium supplements were not given during
the 10 or 11 days of observation. In the patients with
cardiac failure, specific treatment, excluding other
diuretics, was given if indicated. Daily weight and frequent
blood-electrolyte level were recorded in each patient
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Fig. 5. The mean cumulative weight change and the mean
serum potassium level is shown over 11 day of treatment
with trich10rmethiazjde in 17 palien with fluid retention.
from the inhibition of carbonic anhydra e. The more
recent derivative have, howe er, Little carbonic-anhydra e-
inhibiting effect. A the molecule of chlorothiazide ha
been manipulated, so has the effective do e of the
derivatives decrea ed and it ha been uggested that till
increased activity may be due to an increased olubiLity
of the drug in the lipoid of the cell membrane.' A more
specific interference with energy production in the cell
is not, however, excluded, and po ible differences in
electrolyte excretion produced by the different prepara-
tions may result from thi .
The admini tration of 4 mg. of trichlormethiazide twice
daily to 3 normal ubjects re ulted in an increa e in
urine volume, odium, and chloride excretion and, to a
le er extent, pota sium. rinary pH and bicarbonate
excretion were not altered to any considerable extent. In
2 ubjects the ratio of odium to chloride excretion in the
urine increased temporarily and then decrea ed when com-
pared with control level. In the same ubjects imilar
change were noted in the odium: pota ium ratio. The
re ults are con i tent with a primary action on odium
reabsorption and econdary 0 motic diure i . The ab ence
of an increa e in urine pH or bicarbonate excretion
ugge ts little if any carbonic-anhydra e-inhibiting effect of









Days vol. ml. Na K Cl, pH
I - 2 control 1,205 180 33 ·164 6·3
3 1,840 200 34·8 214 6·4
4 1,190 212 40·2 214 6·4
5 1,410 184 38·4 190 6·0
6
7 1,430 105 58·5 177 4·9
2,290 284 91·6 334 5·7
9 1,280 174 67·5 200 5·2
10 1,430 124 89·3 183 5·2
* Effect of 4 mg. of trichlormethiazide twice daily on urinary
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Fig. 3. The effect of an 8 mg. dose of trich10rmethiazide
on urinary output and sodium excretion in respect of its
onset and duration of action is shown.
Fig. 4. The effect of an 8 mg. dose of trichlormethiazide
on potassium, chloride, and urinary pH in respect of its
onset and duration of action is shown.
DISCUSSION
The benzothiadiazines exert their effect, to a large extent,
at the proximal convoluted tubule where they inhibit the
reabsorption of a portion of the filtered sodium. This
results in an osmotic diuresis. Moreover, there i an effect
on the distal convoluted tubule of variable degree resulting
during the course of treatment. The mean cumulative
weight change and the mean serum-potassium change are
shown in Fig. 5. There was no demonstrable alteration in
the other blood electrolytes or urea. Table III shows
the effects of trichlormethiazide on the urinary excretion
of electrolytes in a patient with oedema.
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the 3-benzyl derivative' and to a le er extent with
hydroflumethiazide.· The econdary retention of odium
ob erved after a few day uggests that a compen atory
mechanism to restore body odium began to exert an
effect. This may be due to increa ed ecretion of aldo te-
rone as evidenced by a decrea e in the odium-pota ium
ratio and i to be expected in normal ubjects depleted
of water and odium.' It is unlikely that other diuretics
with similar modes of action would differ in this respect.
There wa no marked increase in the ab olute amount
of pota ium excreted, except in one subject in which a
greater urinary excretion was seen to follow the admini-
tration of pota ium upplements. Similar ob ervation ,
that trichlorrnethiazide and bendroflumethiazide tend to
cau e les pota ium 10 than chlorothiazide, hydrochlor-
thiazide, flumethiazide and hydroflumethiazide, have
been made by Bern tein.· A greater carbonic-anhydra e-
inhibiting effect of the latter ub tances may account for
this.
A single dose of 8 mg. of trichlormethiazide was found
to exert an action within 6 hour of administration. The
effect continued for 24 - 36 hour and wa observed to
abolish the normal diurnal rhythm of water and electrolyte
excretion in the urine (subject 2, Figs. 2 and 3). It has
al 0 been stated that there is a continued water diure is
without electrolyte 10 s following cessation of continuous
therapy of 7 days duration." Thi ha been a sociated with
a decrease in serum osmolarity produced by the previous
treatment. It would appear then that trichlorrnethiazide
has a long duration of action and may be better given in
intermittent cour es with contioued diuretic effect both
during and for a period after stopping the drug. If
administered in this manner, hyponatraemia, which pre-
umably may develop on continuous therapy, would not
occur.
Sati factory diuresis was observed in the 17 patients
treated with trichlormethiazide. There was a mean cumu-
lative weight loss of St lb. in the e patients in 1 week.
Comparisons with other diuretics cannot be made
accurately with this heterogenous group of patients. The
diuresis observed was atisfactory while the rate of clinical
improvement was similar to the expected results with other
diuretics, and Ford7 has shown that S mg. of trichlor-
methiazide i equivalent to 2 m!. meralluride in natriuretic
effect. In some patients the weight increased after a week,
and was una ociated with signs of fluid retention. It is
considered likely that this resulted from an increase in
food intake and consequent increase in actual body solids.
Although during the period of treatment there wa no
drop in the mean serum-potassium level, in some patients
a small decre:;.se was ob erved. Thus, although potassium
depletion may be less likely to occur with this than with
pre ious preparation , as judged by comparative urinary
excretion, it may still be neces ary to supplement pota -
sium intake. During the period of observation no signifi-
cant change in other blood electrolytes or the blood urea
was observed, although in subsequent patients on high
do age a rise in blood urea has been observed in some.
with the other benzothiadiazine derivatives, it i likely
that in patient with renal insufficiency, worsening of
kidney function may occur with vigorous sodium deple-
tion. Care should be exercised in these cases. Similarly,
an increase in the serum uric-acid level may occur with
trichlormethiazide as with any of the benzothiadiazines.
The LDs. dose of trichlorrnethiazide is given as 2·g g./kg.
in mice. Hydrochlorothiazide has a similar LD•• dose, but,
because of the larger dose necessary to produce a diureti
effect, the therapeutic ratio is not as high as for trichlor-
methiazide." This may be of advantage in that toxic effects
would be less likely to occur with the smaller dose required
when using trichlorrnethiazide. However, the therapeutic
ratio is still considerable with the other benzothiadiazines
and well within the toxic dose. Idiosyncrasies are inde-
pendent of dose and may occur with either. In this series
of subjects and in other patients treated concomitantly,
no side-effects, toxic effects, or idiosyncrasies \ ere
ob erved.
SUMMARY AND CONCLUSIONS
The effects of trichlormethiazide, a benzothiadiazine
derivative, were observed in S normal subjects and in 17
patients with fluid retention.
Increased excretion of sodium, chloride, water, and to
a lesser extent potassium, was observed after administra-
tion of 4 mg. twice daily to normal subjects. The effect
was measurable within 6 bours and persisted for 24 - 36
hours.
In the patients with fluid retention a satisfactory diuretic
response was observed. Potassium depletion was slight and
may be less than that reported for Qther benzothiadiazine
derivatives.
o side-effects, toxic effects, or idiosyncrasies to the
drug were noted.
We wish to thank Prof. G. A. Elliott for his encouragement
and criticism, Messrs. V. oble, M. Brooks and . We ton
for technical as istance, and the Photograpbic Unit of the
Department of Medicine for the illustrations.
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THE SECOND WORLD CONFERE CE 0 IJEDICAL EDUCATIO *
B. J. KAPLA , M.B., B.Ch., Senior Lecturer in Social Medicine, University of Cape Town
The .econd World Conferen.ce on Medical Education was McMurray of Cape Town, Dr. B. Kaminer of Johannesburg.
held ID Palmer House, Chicago, from 30 August to 4 and my elf. Delegates came from 65 of the 98 medi aJ
eptember 1959. About 650 delegates attended from 66 chools in the USA and and it is estimated that about
cou~tries, more than half the de~egates being from countries 60,000 students graduate annually from tbe 555 medical
outSide the USA. Three South AfrIcans were pre ent, Mr. T. B. schools which were represented. One example of the progres
of medical education is the fact that there are now 6
• Received for publication on 13 January 1961. medical schools in India.
